Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Healthcare Company (ACHC) Return on Sales (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Return on Sales for 15 consecutive years, with 1.43% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 148.0% to 1.43% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.33%, a 41.0% decrease, with the full-year FY2025 number at 0.33%, down 41.0% from a year prior.
  • Return on Sales was 1.43% for Q4 2025 at Acadia Healthcare Company, down from 0.04% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.13% in Q2 2022 to a low of 1.43% in Q4 2025.
  • A 5-year average of 0.07% and a median of 0.04% in 2025 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: surged 155bps in 2021, then tumbled -148bps in 2025.
  • Acadia Healthcare Company's Return on Sales stood at 0.01% in 2021, then soared by 2261bps to 0.12% in 2022, then crashed by -139bps to 0.05% in 2023, then skyrocketed by 194bps to 0.04% in 2024, then crashed by -3409bps to 1.43% in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Return on Sales are 1.43% (Q4 2025), 0.04% (Q3 2025), and 0.04% (Q2 2025).